Category: Clinical Trials

Medicare proposal covers acupuncture for back pain study participants: A prelude to full coverage?

Medicare coverage of acupuncture is under consideration. A new proposal would provide coverage to Medicare patients participating in studies of acupuncture for back pain. This research would be used in making a final decision.

/ July 18, 2019

New Drug Is Effective for Post-Partum Depression, But There Are Drawbacks

A new drug promises to cure postpartum depression, but it is restricted and patients must be hospitalized for a 60-hour IV infusion.

/ June 25, 2019

“Young blood” infusions: same old snake oil

There's no reliable evidence that an infusion of blood plasma from a young donor will benefit an older person, and there are risks, but Ambrosia Health is selling "young blood" infusions for thousands of dollars anyway. The FDA has taken notice.

/ June 20, 2019

Dubious for-profit stem cell clinics: Co-opting ClinicalTrials.gov as a marketing tool

Over twenty years ago, cancer quack Stanislaw Burzynski pioneered the abuse of the clinical trial process as a marketing tool to sell his antineoplastons. Now, for-profit stem cell clinics are using ClinicalTrials.gov as a marketing tool for their unproven therapies by listing dubious and scientifically worthless trials in this government database. What can be done?

/ June 17, 2019

The FDA’s accelerated drug approval program is failing to protect cancer patients

Drug approval is a process that should be and, for the most part, is rooted in rigorous science. However, there is always a countervailing pressure to approve new drugs rapidly, particularly in cancer. That's why the FDA created the accelerated approval program in the early 1990s. Unfortunately, increasingly this approval process appears to be failing us in oncology. Reform is needed.

/ June 3, 2019

Stem Cells for Knee Arthritis

Stem cell treatments for knee arthritis are not yet ready for prime time, but that has not stopped their premature commercialization.

/ May 22, 2019

The Best Science from The New England Journal of Medicine

The editor-in-chief of The New England Journal of Medicine has selected a dozen articles published during his tenure that epitomize the best of science-based medicine.

/ May 21, 2019

Coca-Cola and Corporate Sponsored Research

A new study reveals that Coca-Cola included restrictive clauses in some research funding contracts. This is a good opportunity to review how such behavior can be stopped.

/ May 8, 2019

Chronic Fatigue Syndrome and Rituximab

IV rituximab has been used to treat chronic fatigue syndrome. A large, well-designed new study shows it doesn't work.

/ April 16, 2019

Medical Apartheid

Harriet Washington's book tells the dark history of medical experimentation on black Americans. It also reveals broader problems of inequality, poor science, and human failures.

/ April 9, 2019